Skip to content
2000
Volume 9, Issue 2
  • ISSN: 1568-0096
  • E-ISSN: 1873-5576

Abstract

Myc family genes are often deregulated in embryonal tumors of childhood including medulloblastoma and neuroblastoma and are frequently associated with aggressive, poorly differentiated tumors. The Myc protein is a transcription factor that regulates a variety of cellular processes including cell growth and proliferation, cell cycle progression, differentiation, apoptosis, and cell motility. Potential strategies that either inhibit the proliferation-promoting effect of Myc and/or activate its pro-apoptotic function are presently being explored. In this review, we will give an overview of Myc activation in embryonal tumors and discuss current strategies aimed at targeting Myc for cancer treatment.

Loading

Article metrics loading...

/content/journals/ccdt/10.2174/156800909787580962
2009-03-01
2025-09-03
Loading full text...

Full text loading...

/content/journals/ccdt/10.2174/156800909787580962
Loading

  • Article Type:
    Research Article
Keyword(s): brain tumor; Cancer; child; Myc; neuroblastoma; targeted therapies
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test